Osimertinib for treating locally advanced or metastatic EGFR and T790M mutation-positive non-small cell lung cancer [ID874]: A Single Technology Appraisal.

Greehalgh, Janette, Aslam, Rabeea'h Waseem ORCID: https://orcid.org/0000-0002-0916-9641, Mahon, James, Krishan, Ashma, Boland, Angela, Beale, Sophie, Kotas, Eleanor, Banks, Lindsay and Green, John 2016. Osimertinib for treating locally advanced or metastatic EGFR and T790M mutation-positive non-small cell lung cancer [ID874]: A Single Technology Appraisal. [Technical Report]. National Institue of Clinical Excellence. Available at: https://www.nice.org.uk/guidance/ta653/documents/c...

PDF - Published Version Download (13MB)

Item Type:	Report (Technical Report)
Date Type:	Publication
Status:	Published
Schools:	Schools > Social Sciences (Includes Criminology and Education)
Publisher:	National Institue of Clinical Excellence
Date of First Compliant Deposit:	21 March 2025
Last Modified:	14 Jul 2025 14:15
URI:	https://orca.cardiff.ac.uk/id/eprint/177062

Actions (repository staff only)

Edit Item